HIV / AIDS (Stage III)
Georgia’s Medical Cannabis Patient Registry lists human immunodeficiency virus (HIV) when the disease is diagnosed as Stage III as a qualifying condition. AIDS, or acquired immunodeficiency syndrome, is the most advanced stage of HIV infection. A Georgia-licensed physician reviews your records and medical history before deciding whether to certify you.
$100 · Private 15-minute phone consultation with a Georgia-licensed physician. GMMC serves adults age 18 and older throughout Georgia.
Book on Calendly. Our team sends an eVisit link for your telemedicine visit. The consultation fee is collected through eVisit after your visit. If our physician determines that you do not qualify for medical cannabis certification, we will refund any consultation fee you paid. State card fees are separate.
This page explains eligibility, consultation preparation, and research about medical marijuana for AIDS. Certification does not establish that cannabis will improve your symptoms, treat HIV, or replace antiretroviral therapy.
Does AIDS Qualify for a Medical Cannabis Card in Georgia?
The Georgia Department of Public Health’s patient guidance includes HIV diagnosed as Stage III. An HIV diagnosis at another stage does not automatically satisfy this specific qualifying condition.
The certifying physician must be fully licensed, have a principal practice location in Georgia, and make the certification decision using medical judgment. An appointment, payment, or website checklist does not guarantee approval.
Keep available documentation of your diagnosis and current care. The physician determines what information is needed to review eligibility. GMMC’s service is for adults age 18 and older statewide.
Other qualifying conditions have their own criteria. See our Georgia eligibility guide for the complete program overview rather than assuming all HIV-related symptoms qualify independently.
HIV Infection, AIDS, and the Immune System
HIV is the virus that causes HIV infection. It affects immune defenses and, without treatment, can progress to AIDS. The NIH guide to the stages of HIV infection describes three stages: acute infection, chronic infection, and AIDS.
Early infection may involve flu-like symptoms, while chronic infection can occur without obvious symptoms. AIDS involves substantial immune-system damage and vulnerability to opportunistic infections. Your medical records and clinician’s assessment establish your diagnosis; symptoms alone cannot determine the stage.
A weakened immune system may have difficulty fighting infections. However, effective HIV treatment can help even after an AIDS diagnosis. Continue medical care rather than treating a cannabis evaluation as a replacement for your infectious-disease team.
Antiretroviral Therapy Remains Essential
Antiretroviral therapy, often abbreviated ART, uses HIV medicines to control the virus. NIH explains that ART reduces the amount of HIV in the blood and supports long-term health. Cannabis does not replace these medications.
Do not stop antiretroviral drugs, change their timing, or substitute marijuana use because of a registry certification. If nausea, pain, or other medical symptoms interfere with taking your medicines, tell your treating healthcare provider.
A consultation about medical cannabis eligibility is separate from ongoing HIV management. Keep your established appointments, laboratory monitoring, and prescribed treatment plan.
Medical Marijuana Research for HIV/AIDS Symptoms
Patients may ask about pain and symptom management, appetite loss, nausea, weight loss, or nerve pain. Those are important questions, but evidence differs by symptom and by the product studied.
Research on medicinal cannabis includes small clinical trials, older studies, and reviews with important limitations. A result involving a specific medicine or supervised research product cannot automatically be applied to every dispensary product.
The Cochrane review of medical cannabis use in people with HIV/AIDS found limited evidence, concerns about bias, and insufficient longer-term data. It did not establish a survival benefit. This review is older, but its limitations remain important when interpreting claims based on the studies it assessed.
Discuss potential health effects with your HIV clinician or pharmacist. A medical card provides access within the state program; it is not proof of benefit for an individual.
Appetite Loss, Body Weight, and Wasting
Unintentional weight loss or difficulty eating needs medical assessment. Your care team can investigate the cause and discuss nutrition, treatment options, and medication effects. A desire to stimulate appetite is not the same as evidence of sustained weight gain or recovery of muscle.
The FDA’s prescribing information for MARINOL identifies dronabinol as a prescription medicine used in adults for anorexia associated with weight loss in AIDS. Its separate indication for certain chemotherapy-related nausea and vomiting should not be interpreted as approval for every cause of nausea.
An approved prescription cannabinoid medicine and medical cannabis purchased through Georgia’s registry are different products and pathways. The prescription indication does not prove that all cannabis formulations have equivalent effects.
Ask about realistic goals such as appetite, caloric intake, body weight, function, and adverse effects. Do not rely on claims that cannabis necessarily reverses AIDS wasting syndrome.
Neuropathic Pain and Peripheral Neuropathy
People living with HIV may experience peripheral neuropathy and neuropathic pain. Describe burning, tingling, numbness, or other nerve symptoms to your treating clinician. The cause and treatment plan require individual assessment.
A 2007 randomized placebo-controlled trial examined smoked cannabis for painful HIV-associated sensory neuropathy over a short treatment period. It is evidence about a specific study population and intervention, not a recommendation to smoke marijuana or a long-term treatment guarantee.
A separate randomized crossover clinical trial published in 2009 investigated smoked medicinal cannabis for HIV-related neuropathic pain. These studies should be considered in the context of their design, duration, and limitations.
Smoking marijuana in a research trial does not establish what Georgia allows or what would be appropriate for you. This page gives no smoking recommendation or trial-based dosing schedule.
See our Peripheral Neuropathy page for general education about that separate qualifying condition and current severe-symptom criterion.
Nausea, Vomiting, and Other Medical Symptoms
If nausea or vomiting affects hydration, nutrition, or medication adherence, discuss it with your healthcare provider. Treatment should address the cause and consider your current medicines.
Research about cannabinoids for chemotherapy-related nausea cannot be assumed to prove the same result for HIV medications or every gastrointestinal problem. Not everyone responds the same way, and some products can produce unwanted effects.
This page does not promise relief, increased food intake, or improved ART adherence from cannabis use. Bring questions about symptoms and previous treatments to the clinician who manages your HIV care.
Anxiety, Depression, and Quality of Life
Living with a chronic condition can involve concerns about mood, sleep, stigma, and everyday life. Those concerns deserve appropriate care. They do not establish that cannabis is an effective treatment for anxiety or depression.
The NIH cannabis overview describes effects on thinking, memory, movement, and perception, as well as possible unwanted effects. A claim that a product improves mood should be weighed against its risks and the strength of supporting evidence.
Tell the physician about your mental-health history, prior reactions to cannabis, and any other substances you use. Continue established mental-health care and avoid changing medication based on website content.
Medication Review and Medical Supervision
People with HIV may take several medications, including ART and medicines for other conditions. The full list helps clinicians review possible interactions and overlapping adverse effects.
Bring prescription medications, nonprescription products, vitamins, and supplements to the discussion. Include any cannabis products you already use. A clinician or pharmacist can evaluate the actual regimen rather than relying on broad statements that a combination is always safe.
Cannabis may cause dizziness, drowsiness, or impaired memory and attention. These effects can matter when taking other medicines or managing complex daily routines. Avoid driving or safety-sensitive activities while impaired.
Your individual health, immune status, and medication history matter more than a website’s generic dose or THC-to-CBD ratio. This page does not prescribe a dose, recommend vaporization, or promise that a delivery method is safe for an immunocompromised patient.
Preparing for Your Stage III HIV Evaluation
Gather available records documenting your diagnosis and care. The physician decides which documentation is necessary; not every patient needs to obtain every possible test before asking about a consultation.
Useful preparation includes:
Available records identifying your Stage III HIV or AIDS diagnosis
Your current ART regimen and other medication list
Relevant treatment history and known medication allergies
A short list of your questions about eligibility and safety
Current identity and Georgia residency documentation
Ask the team about secure submission of medical records. Do not place HIV history, laboratory reports, identity documents, or other private health information in the public website contact form.
A family member may help organize questions or scheduling. That assistance does not automatically establish caregiver authorization to possess medical cannabis; DPH has separate patient and caregiver instructions.
How to Get a Medical Cannabis Card in Georgia
The consultation and the state registry have distinct steps:
Book your adult consultation: Select your appointment on Calendly for a private 15-minute phone consultation.
Receive the eVisit link: Our team sends the link for your telemedicine visit. Ask about secure record submission or appointment arrangements when needed.
Attend the physician evaluation: The Georgia-licensed physician reviews your diagnosis, medical history, and eligibility.
Pay through eVisit after the visit: The consultation is $100. If our physician determines that you do not qualify, we will refund any consultation fee you paid.
Complete state verification if certified: The physician submits the required information. DPH verifies it and sends payment instructions.
Receive your state card: Follow DPH’s delivery instructions. Allow up to 10 business days after state payment processing.
Booking does not automatically enroll you in the registry. A physician certification decision and state processing are required. GMMC provides the consultation service; DPH issues the state card.
State Fees, Card Validity, and Annual Certification
DPH’s state card fee is $30, with a $3.75 service fee when using its online payment portal. These fees are separate from the $100 GMMC consultation and any product purchases.
The card is valid for five years. Annual physician certification is generally required, so the certification schedule and printed expiration date are different. Georgia law exempts patients with incurable or irreversible conditions from annual certification. Confirm whether this applies to your documented condition and registry record with your certifying physician or Georgia DPH. Review the certification exception and card renewal.
Follow DPH’s current instructions for identity, residency, payment, and card delivery. The old Low THC Oil Registry name still appears in historical materials; DPH states that existing unexpired cards remain valid.
Current Georgia Possession and Product Guidance
DPH currently lists a possession limit of 12,000 milligrams of THC for registered patients and caregivers. Registry access does not authorize unrestricted cannabis possession or override federal law.
Check the Georgia Access to Medical Cannabis Commission for current product rules and licensed dispensaries. Do not assume that a product available in another state is permitted in Georgia.
Ask official sources and licensed dispensaries about available formulations. A possession limit is a legal ceiling, not a recommended dose or a measure of what is medically appropriate.
Frequently Asked Questions About Medical Marijuana for AIDS
Does Any HIV Diagnosis Qualify?
Georgia’s listed HIV condition specifies Stage III. A physician reviews the documentation and medical judgment determines certification. An HIV diagnosis alone is not automatic approval under this criterion.
Is AIDS the Same as an HIV-Positive Test?
No. HIV is the virus, while AIDS (acquired immunodeficiency syndrome) is the most advanced stage of HIV infection. Your treating clinician and records establish the diagnosis. A positive test by itself does not establish Stage III.
Does Cannabis Treat HIV or Replace ART?
No. Cannabis does not replace antiretroviral therapy or ongoing HIV medical care. Keep taking prescribed medicines and discuss side effects with your treating clinician.
Can GMMC See Adults Anywhere in Georgia?
Yes. GMMC offers a private 15-minute phone consultation for adults age 18 and older statewide. Book on Calendly and use the eVisit link sent by our team.
When Do I Pay for the Consultation?
Payment is collected through eVisit after your visit. The consultation fee is $100. State card fees are paid separately through the state process.
What Happens if I Do Not Qualify?
If our physician determines that you do not qualify for medical cannabis certification, we will refund any consultation fee you paid. This is a service, with no merchandise to return.
Can I Send Medical Records Through the Website Contact Form?
Use the contact page for general booking assistance. Ask the team about secure record submission; do not include HIV history, lab reports, or identity documents in the public form.
Will a Card Guarantee Appetite Improvement or Pain Relief?
No. Eligibility and symptom response are different questions. Studies have limitations, and a registry card does not establish that a particular product will benefit you.
Book Your Adult Consultation
If you have documented Stage III HIV and want to discuss Georgia medical cannabis eligibility, gather available records and your medication list, then choose your appointment.
$100 · Private 15-minute phone consultation · Adults 18+ throughout Georgia.
Our team sends your eVisit link. Payment is collected through eVisit after your visit. If our physician determines that you do not qualify, we will refund any consultation fee you paid.
See pricing and fees, the consultation refund policy, and booking assistance.
This page provides general education and does not replace personalized medical advice, diagnosis, or treatment.